These results indicate that the high levels of CSF2-Ab may reduce p53 activity via adsorption of CSF2 in the circulation, leading to an increase in the proliferation of cancer cells and unfavorable prognosis in patients with CRC (Figure 6D). The gene discussed is TP53; the disease is colorectal carcinoma.